Sun Pharm Drug Patent Portfolio

Sun Pharm's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sun Pharm News

Indian Pharmaceutical Companies Set to Introduce Generic Semaglutide Following Ozempic Patent Expiration

17 Mar, 2026

Novo Nordisk dismisses the possibility of a price war with the introduction of semaglutide generics in India - Business Standard

17 Mar, 2026

Producers of generic medications are gearing up to introduce cost-effective alternatives following the expiration of Novo's patent for ... - Mint

16 Mar, 2026

Affordable Generic Ozempic Set to Arrive in India: Patent Expiration Triggers Surge in Weight-Loss Medications - NDTV

16 Mar, 2026

See More